Navigation Links
World Debut for BSP's HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
Date:3/25/2008

TEL AVIV, Israel, March 25 /PRNewswire/ -- BSP Ltd. (http://www.bsp.co.il/pressall.asp), an Israeli company which develops and markets systems for non-invasive diagnosis and monitoring of ischemic heart disease, will be launching their HyperQ(TM) Stress System in the US during the 57th Annual ACC 08 Meeting in Chicago, IL.

The HyperQ(TM) is cutting-edge technology implemented in an innovative stress-test system, offering highly reliable, low-cost and risk free cardiac monitoring for broad populations and allows, for the first time, effective and accurate testing for Ischemic heart disease patients.

The HyperQ(TM) system received FDA clearance (510K), as well as the European CE marking. To date, more than 3500 patients in Israel, Europe and the US have been examined by HyperQ(TM) Stress Systems in controlled clinical studies, pilot programs and routine testing in the setting of private offices and hospital clinics. The results have demonstrated the system's high efficiency and unmatched accuracy in the diagnosis of IHD.

The company has entered the clinical and commercial phase, during which the HyperQ(TM) Stress System will be integrated in inpatient settings, outpatient cardiology departments, private doctor offices and major research centers.

Further applications on the company's scope, based on the same core technology, include bedside monitors for ischemic events; devices for cardiac home-care and telemedicine; periodic check-up systems, and the implementation of the HyperQ(TM) technology in implantable cardiac devices such as pacemakers and defibrillators.

Dr. Amir Beker, CEO of BSP says, "BSP's HyperQ(TM) technology is a revolutionary solution to today's most fatal pathology. The HyperQ(TM) Stress System is a non-invasive solution that will improve the standard of care for cardiac patients and at the same time will help reduce unnecessary costly and potentially harmful procedures. The HyperQ(TM) Stress System thus addresses dire needs of private and national healthcare systems to balance the immense costs of cardiac diagnosis and monitoring, while decreasing the risk of further, often invasive, tests for cardiac patients".

About BSP

BSP is dedicated to providing novel, risk free and highly reliable solutions for the diagnosis and monitoring of Ischemic Heart Disease. BSP was founded in 2000 by Dr. Amir Beker and Mr. Ariel Landau and has completed a successful IPO in mid-2006 and its shares are traded on the Tel Aviv Stock Exchange.

Contact: Dr. Amir Beker, +972-3-6474840, http://www.bspmedical.com


'/>"/>
SOURCE BSP - Biological Signal Processing Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nanoscience will change the way we think about the world
2. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
4. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
5. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
6. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
7. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer
8. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
9. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
10. World Glaucoma Day Set for March 6th
11. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Washington, DC (PRWEB) , ... ... ... Technologies Consortiumâ„¢ (ETC), a consortium of pharmaceutical and biotechnology companies dedicated to ... is seeking companies interested in supplying a vendor-supported, portable online UHPLC, with ...
(Date:12/2/2016)... Laboratories, a world leader in rapid infectious disease tests, introduced the Company,s newest product, ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited by ... the INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... , Nov. 30, 2016 /PRNewswire/ - Portage Biotech ... Securities Exchange: PBT.U), is excited to announce the ... focused on developing preclinical ophthalmology assets through proof ... potent anti-inflammatory created by Portage Pharmaceuticals Limited and ... with ocular surface and anterior segment diseases. This ...
(Date:11/30/2016)...  Tempus, a technology company focused on supporting ... Cancer Center have partnered to better determine which ... treatment based on next generation genomic and transcriptomic ... research collaboration, Tempus will provide sequencing and analysis ... to Penn. Utilizing next-generation sequencing, machine learning and ...
Breaking Biology Technology:
(Date:11/14/2016)... CLARA, Calif. , Nov. 14, 2016 ... the biometric identification market, Frost & Sullivan ... Frost & Sullivan Award for Visionary Innovation ... player in the biometric identification market by ... multi-modal verification solution for instant, seamless, and ...
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
Breaking Biology News(10 mins):